AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2021

Mar 15, 2021

33003_dirs_2021-03-15_957de0ca-83f1-4483-b537-9ad7419af9de.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2021-03-12

Reporting Person: Schneider Joel Solomon Zev (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-12	Common Stock	S	11699	$8.8442	Disposed	280473	Direct
2021-03-12	Common Stock	S	11699	$8.8428	Disposed	268774	Direct

Footnotes

F1: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1) adopted by the reporting person on May 12, 2020.